Business in the Burbs

Progenics to move ahead with HIV treatment

February

Progenics Pharmaceuticals Inc., a Tarrytown-based biotech company, said that the company plans further development of an injectable treatment for HIV infection known as PRO 140. Progenics said that the decision follows positive results from a study of the treatment and positive comments from treatment advocates and people living with HIV. Progenics added that the study showed that PRO 140 perfomed better than a placebo and was well tolerated by patients.

This entry was posted on Tuesday, February 10th, 2009 at 1:59 pm by Jay Loomis. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.